American Origin Unverified This profile is unclaimed and has not been independently reviewed. Claim & get verified

Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR (JHPCY)

$13.60 -13.04% OTC: JHPCY · 15-min delayed

Public · OTC: JHPCY

JHPCYOTC

About Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR

JIANGSU HENGRUI PHARM CO

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Company facts

Type: Public · OTC: JHPCY

Incorporation record

Incorporated in: CN — outside the United States
Registered office: Lianyungang, CN
Legal entity ID: 2549003BT1XS3SE3E448

Source: GLEIF, the global Legal Entity Identifier registry · checked Aug 8, 2026. A US headquarters does not always mean US incorporation. Is Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR an American company? See the full verdict →

Registry IDs

Ticker: JHPCY OTC
SEC CIK: 2071868
LEI: 2549003BT1XS3SE3E448

Explore our data studies: the biggest company in every US state · all rankings & reports.

Embed this company’s badge

Show Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR’s American-company profile badge on a website — copy this HTML:

<a href="https://americancompanies.com/company/jiangsu-hengrui-pharmaceuticals-co-ltdadr/"><img src="https://americancompanies.com/badge/jiangsu-hengrui-pharmaceuticals-co-ltdadr.svg" alt="Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR — American company profile on americancompanies.com" width="220"></a>

Is this your company?

This profile is unclaimed — any authorized owner can claim it free, control the page, and activate the embeddable Verified badge for their own website.

Claim this profile — free

Track American companies

Create a free account to follow Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR and get an email when it moves sharply — real market data, 15-minute delayed.

Create free account

OTC: JHPCY

$13.60 -13.04%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$13.60 $18.00

52-week range

Dividend yield: 0.43%
Open: —
Day range: –
Prev close: —
Volume: —

Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR (JHPCY) Stock Price

Trading 24% below its 52-week high.
Pays a dividend yielding about 0.43% annually.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

No reviews yet. Be the first to review Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR.

Write a review

Newsroom

News about Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR

Hengrui Pharma and Kailera Therapeutics Present Ribupatide Clinical Data at ADA 2026 GlobeNewswire Inc. · 2026-06-05 · positive Precision-Drug maker Impact Therapeutics Ignites IPO Frenzy Benzinga · 2026-05-14 · neutral Kailera Therapeutics' Strong IPO Validates "NewCo" Strategy Benzinga · 2026-04-23 · positive Kailera Therapeutics Announces Pricing of Initial Public Offering GlobeNewswire Inc. · 2026-04-16 · positive Elevar Therapeutics Announces FDA Acceptance of New Drug Application Resubmission for Rivoceranib in Combination with Camrelizumab as a First-line Systemic Treatment for Unresectable Hepatocellular Carcinoma GlobeNewswire Inc. · 2026-01-30 · positive Endometriosis Clinical Trial Pipeline Accelerates as 18+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight GlobeNewswire Inc. · 2026-01-22 · positive

News & sentiment via Polygon.io

FAQ

Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR: frequently asked questions

Is Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR an American company?

Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR is a US-based company, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.

Is Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR publicly traded?

Yes — Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR is a publicly traded company. Its stock trades under the ticker symbol JHPCY on the OTC.

Explore